Literature DB >> 2835193

Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteers.

K A Callow1, D A Tyrrell, R J Shaw, P Fitzharris, A J Wardlaw, A B Kay.   

Abstract

In an attempt to understand the relationship between viral upper respiratory tract infection and the underlying virological and immunological mechanisms, thirty-four volunteers were inoculated intranasally with coronavirus 229E; subsequent virus shedding and/or antibody rises, indicating active infection, were observed in twenty-nine. There was a greater increase in independently measured scores of clinical severity, e.g. cold symptoms, in those with detectable IgE in nasal secretions (P less than 0.01). A similar association was found between clinical scores and serum IgE concentrations greater than or equal to 150 IU/ml, but the relationship with systemic atopy, as assessed by skin-prick tests to common allergens, was less marked. A more detailed study of twelve of the infected volunteers failed to explain these findings on the basis of mast cell mediator release, as concentrations of leukotriene B4, the sulphidopeptide leukotriene C4, and histamine, were not appreciably elevated in the nasal secretions following virus inoculation. Similarly, there was no evidence that circulating coronavirus specific IgE was produced. Thus, this study suggest that atopy may be related to the severity of cold symptoms produced by coronavirus 229E, although the exact connection has yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835193      PMCID: PMC7194196          DOI: 10.1111/j.1365-2222.1988.tb02851.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  36 in total

1.  Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man.

Authors:  W T Butler; T A Waldmann; R D Rossen; R G Douglas; R B Couch
Journal:  J Immunol       Date:  1970-09       Impact factor: 5.422

2.  Presence of gammaE in nasal washings and sputum from asthmatic patients.

Authors:  K Ishizaka; R W Newcomb
Journal:  J Allergy       Date:  1970-10

3.  IgE concentrations in children with atopic diseases. A clinical study.

Authors:  T Berg; S G Johansson
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

4.  Human IgE.

Authors:  R S Geha
Journal:  J Allergy Clin Immunol       Date:  1984-08       Impact factor: 10.793

5.  Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay.

Authors:  E C Hayes; D L Lombardo; Y Girard; A L Maycock; J Rokach; A S Rosenthal; R N Young; R W Egan; H J Zweerink
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

Review 6.  Regulation of IGE synthesis in man.

Authors:  D Y Leung; R S Geha
Journal:  Clin Immunol Rev       Date:  1984

7.  Preferential generation of leukotriene C4 by human eosinophils.

Authors:  R J Shaw; O Cromwell; A B Kay
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

8.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.

Authors:  R C Welliver; D T Wong; M Sun; E Middleton; R S Vaughan; P L Ogra
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

9.  Local and serum IgE in vasomotor rhinitis.

Authors:  J J Braun; G Pauli; J C Bessot; R Thierry; C Conraux
Journal:  Rhinology       Date:  1982-03       Impact factor: 3.681

10.  An introduction to allergic disease.

Authors:  M Haeney
Journal:  J R Coll Physicians Lond       Date:  1985-07
View more
  14 in total

1.  A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers.

Authors:  P G Higgins; G I Barrow; D A Tyrrell
Journal:  Antiviral Res       Date:  1990-12       Impact factor: 5.970

2.  Signs and symptoms in common colds.

Authors:  D A Tyrrell; S Cohen; J E Schlarb
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

3.  Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects.

Authors:  R M Wadowsky; S M Mietzner; D P Skoner; W J Doyle; P Fireman
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

4.  The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha.

Authors:  Bing Zhou; Junli Liu; Qiuna Wang; Xuan Liu; Xiaorong Li; Ping Li; Qingjun Ma; Cheng Cao
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

5.  Some recent work at the Common Cold Unit, Salisbury.

Authors:  D A Tyrrell
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

6.  The effect of intranasal nedocromil sodium on viral upper respiratory tract infections in human volunteers.

Authors:  G I Barrow; P G Higgins; W al-Nakib; A P Smith; R B Wenham; D A Tyrrell
Journal:  Clin Exp Allergy       Date:  1990-01       Impact factor: 5.018

Review 7.  The common cold.

Authors:  G L Kirkpatrick
Journal:  Prim Care       Date:  1996-12       Impact factor: 2.907

8.  Atopic status protects from severe complications of COVID-19.

Authors:  Enrico Scala; Damiano Abeni; Alberto Tedeschi; Giuseppina Manzotti; Baoran Yang; Paolo Borrelli; Alessandro Marra; Mauro Giani; Antonio Sgadari; Francesca Saltalamacchia; Riccardo Asero
Journal:  Allergy       Date:  2020-09-07       Impact factor: 14.710

9.  The Use of Antiallergic and Antiasthmatic Drugs in Viral Infections of the Upper Respiratory Tract.

Authors:  Nils Åberg
Journal:  Clin Immunother       Date:  2012-11-18

10.  Amplified rhinovirus colds in atopic subjects.

Authors:  P G Bardin; D J Fraenkel; G Sanderson; M Dorward; L C Lau; S L Johnston; S T Holgate
Journal:  Clin Exp Allergy       Date:  1994-05       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.